Bioequivalency testing symposium
Sept. 16-17 conference, to be co-sponsored by the American Pharmaceutical Association (APhA) and the Academy of Research and Science, includes as speakers FDA Commissioner Young and FDA Office of Drug Standards Director Peter Rheinstein. Symposium on "The Scientific and Regulatory Aspects of Bioequivalency Testing" will take place at the Bethesda (Maryland) Marriott Hotel. Moderator and coordinator is Marvin Meyer, professor of pharmaceutics, University of Tennessee College of Pharmacy. For further information contact APhA, 2215 Constitution Ave., NW, Washington, DC 20037.
You may also be interested in...
Akcea Therapeutics has lowered its asking price in England for its antisense therapy for familial chylomicronaemia syndrome. It has also struck a pricing and reimbursement deal for the drug in Germany.
Fresenius Kabi must pay Eli Lilly €28m in damages after a French court of first instance found that the generics firm’s pemetrexed infringed intellectual property protecting the Alimta chemotherapy brand. The German firm has commented on possible next steps.
Japanese ophthalmic specialist picks up young private US firm and gains a small but broad set of marketed products.